A Study of LY3832479 (LY-CoV016) in Healthy Participants 1

NCT04611789 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: LY3832479
DRUG: Placebo

Sponsor

Eli Lilly and Company

Collaborators

[object Object]